Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Characterization of a hierarchy in human acute myeloid leukemia progenitor cells

HJ Sutherland, A Blair, RW Zapf

Blood (1996) 87 (11): 4754–4761.

https://doi.org/10.1182/blood.V87.11.4754.bloodjournal87114754

Published: 1996

Journal Articles

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

DE Reece, MJ Barnett, JD Shepherd, DE Hogge, RJ Klasa, SH Nantel, HJ Sutherland, HG Klingemann, RN Fairey, NJ Voss

Blood (1995) 86 (2): 451–456.

https://doi.org/10.1182/blood.V86.2.451.bloodjournal862451

Published: 1995

Journal Articles

Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants

HJ Sutherland, CJ Eaves, PM Lansdorp, GL Phillips, DE Hogge

Blood (1994) 83 (12): 3808–3814.

https://doi.org/10.1182/blood.V83.12.3808.3808

Published: 1994

Journal Articles

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

DE Reece, JM Connors, JJ Spinelli, MJ Barnett, RN Fairey, HG Klingemann, SH Nantel, S O'Reilly, JD Shepherd, HJ Sutherland

Blood (1994) 83 (5): 1193–1199.

https://doi.org/10.1182/blood.V83.5.1193.1193

Published: 1994

Journal Articles

Alternative mechanisms with and without steel factor support primitive human hematopoiesis

HJ Sutherland, DE Hogge, D Cook, CJ Eaves

Blood (1993) 81 (6): 1465–1470.

https://doi.org/10.1182/blood.V81.6.1465.1465

Published: 1993

Journal Articles

Differential regulation of primitive human hematopoietic cells in long- term cultures maintained on genetically engineered murine stromal cells

HJ Sutherland, CJ Eaves, PM Lansdorp, JD Thacker, DE Hogge

Blood (1991) 78 (3): 666–672.

https://doi.org/10.1182/blood.V78.3.666.666

Published: 1991

Journal Articles

Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro

HJ Sutherland, CJ Eaves, AC Eaves, W Dragowska, PM Lansdorp

Blood (1989) 74 (5): 1563–1570.

https://doi.org/10.1182/blood.V74.5.1563.1563

Published: 1989

NARROW

Characterization of a hierarchy in human acute myeloid leukemia progenitor cells

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

Alternative mechanisms with and without steel factor support primitive human hematopoiesis

Differential regulation of primitive human hematopoietic cells in long- term cultures maintained on genetically engineered murine stromal cells

Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro

Email alerts

ASH Publications

American Society of Hematology

Characterization of a hierarchy in human acute myeloid leukemia progenitor cells

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

Alternative mechanisms with and without steel factor support primitive human hematopoiesis

Differential regulation of primitive human hematopoietic cells in long- term cultures maintained on genetically engineered murine stromal cells

Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only